Cost Comparisons between Home- and Clinic-Based Testing for Sexually Transmitted Diseases in High-Risk Young Women
2007

Cost Comparisons of Home vs. Clinic Testing for STDs in Young Women

Sample size: 388 publication Evidence: moderate

Author Information

Author(s): Kenneth J. Smith, Robert L. Cook, Roberta B. Ness

Primary Institution: University of Pittsburgh School of Medicine

Hypothesis

Is home-based testing for sexually transmitted diseases more cost-effective than clinic-based testing for high-risk young women?

Conclusion

Home testing for STDs can be cost-saving when considering all costs, but this depends on changes in clinic testing frequency.

Supporting Evidence

  • Home testing increased the likelihood of STD testing.
  • Direct costs for clinic testing were higher than for home testing.
  • Cost savings were not observed for asymptomatic tests.

Takeaway

This study found that testing for STDs at home can save money compared to going to a clinic, but it only works if fewer people go to the clinic when home testing is available.

Methodology

The study analyzed cost data from the DAISY study, a randomized controlled trial comparing home and clinic testing for STDs.

Potential Biases

Potential bias in self-reported costs and time associated with clinic visits.

Limitations

The analysis may not apply to populations with different access to healthcare or testing behaviors.

Participant Demographics

Young women aged 15-24, with 51% recruited from clinics and 49% from neighborhoods.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2007/62467

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication